Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2883846 | The Annals of Thoracic Surgery | 2006 | 10 Pages |
Abstract
The treatment of patients with coronary artery disease continues to evolve. Recent, exciting data on the use of drug-eluting stents in diseased coronary vessels has generated immense enthusiasm within the interventional community leading to claims that “drug-eluting stents will put bypass surgeons out of business.” However, despite promising short-term and midterm outcomes of this revolutionary new technology, valid concerns regarding long-term safety and efficacy of drug-eluting stents persist. This review article evaluates current status of drug-eluting stents with special emphasis on real and potential drawbacks of this emerging percutaneous coronary interventional modality and its impact on the practice of coronary artery bypass surgery.
Keywords
MIDCABGPESFDAPCISESDESDrug-eluting stentssirolimus-eluting stentspaclitaxel-eluting stentscoronary artery bypass graftingCABGFood and Drug Administrationleft internal mammary arteryconfidence intervalLADLIMApercutaneous coronary interventionRisk ratiohazard ratioARTSleft anterior descending coronary artery
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shahzad G. MRCS,